Applied Finance Capital Management’s Novartis NVS Stock Holding History

Applied Finance Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$981K	Sell	6,260 -911	-13%	-$137K	0.07%	106
2026 Q1	$1.1M	Sell	7,171 -181	-2%	-$27.7K	0.08%	94
2025 Q4	$1.01M	Sell	7,352 -211	-3%	-$27.6K	0.07%	101
2025 Q3	$970K	Buy	7,563 +60	+0.8%	+$7.32K	0.07%	107
2025 Q2	$908K	Sell	7,503 -943	-11%	-$106K	0.06%	134
2025 Q1	$942K	Buy	8,446 +2,148	+34%	+$229K	0.07%	117
2024 Q4	$613K	Sell	6,298 -775	-11%	-$82.6K	0.03%	176
2024 Q3	$814K	Buy	7,073 +2,666	+60%	+$303K	0.03%	142
2024 Q2	$469K	Buy	4,407 +1,278	+41%	+$128K	0.02%	198
2024 Q1	$303K	Hold	3,129	–	–	0.02%	71
2023 Q4	$316K	Sell	3,129 -233	-7%	-$22.5K	0.03%	63
2023 Q3	$342K	Buy	3,362 +230	+7%	+$23.3K	0.04%	53
2023 Q2	$316K	Buy	3,132 +316	+11%	+$31.6K	0.04%	56
2023 Q1	$259K	Buy	2,816 +312	+12%	+$27.2K	0.03%	59
2022 Q4	$227K	Buy	+2,504	New	+$211K	0.03%	61

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Applied Finance Capital Management's NVS Position: Q2 2026 in Review

Applied Finance Capital Management reduced its Novartis (NVS) stake by 13% in Q2 2026, selling an estimated $137K and leaving 6,260 shares worth $981K. The position accounts for 0.07% of the portfolio, ranked #106.

Applied Finance Capital Management first reported a position in NVS in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.1M in Q1 2026. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Applied Finance Capital Management held 6,260 shares of Novartis worth $981K as of Q2 2026.
Applied Finance Capital Management sold 911 Novartis shares in Q2 2026, an estimated $137K.
Novartis made up 0.07% of Applied Finance Capital Management's portfolio in Q2 2026, its #106 holding.
Applied Finance Capital Management first reported a position in Novartis in Q4 2022 and has held it in 15 quarters since.
Applied Finance Capital Management's Novartis position peaked at $1.1M in Q1 2026.
1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Applied Finance Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.